CCL22 and pulmonary fibrosis: It is thus strongly assumed that locally enhanced levels of CCL22 in the respiratory tract, as for instance observed in patients diagnosed for idiopathic pulmonary fibrosis or allergic rhinitis and in experimental asthma models (134–136), are able to promote pulmonary ILC2 recruitment.